Q1 25 EPS
$0.92
BEAT +13.93%
Est. $0.81
Q1 25 Revenue
$3.05B
BEAT +6.31%
Est. $2.87B
vs S&P Since Q1 25
+50.0%
BEATING MARKET
OSCR +80.7% vs S&P +30.7%
Market Reaction
Did OSCR Beat Earnings? Q1 2025 Results
Oscar Health kicked off 2025 with a standout first quarter, posting earnings per share of $0.92 against a consensus estimate of $0.81, a beat of nearly 14%, while revenue of $3.05 billion cleared expectations by 6.31% and surged 42.2% year over year.… Read more Oscar Health kicked off 2025 with a standout first quarter, posting earnings per share of $0.92 against a consensus estimate of $0.81, a beat of nearly 14%, while revenue of $3.05 billion cleared expectations by 6.31% and surged 42.2% year over year. The primary engine behind that revenue acceleration was membership growth, with total effectuated members climbing to roughly 2.04 million from 1.45 million a year earlier, translating premium revenue to $3.00 billion from $2.09 billion in Q1 2024. That scale delivered meaningful operating leverage, driving the SG&A expense ratio down to 15.8% from 18.4%, even as the medical loss ratio edged higher to 75.4% partly due to $31.00 million of unfavorable prior period risk adjustment development. Net income attributable to Oscar reached $275.27 million, with adjusted EBITDA rising to $328.83 million. The company, which has centered its ACA marketplace strategy on tech-powered plan design and specialized chronic condition offerings, reaffirmed its full year 2025 outlook, continuing to guide for meaningful margin expansion ahead.
Key Takeaways
- • Higher membership driving 42% year-over-year revenue growth
- • Fixed cost leverage reducing SG&A expense ratio to 15.8% from 18.4%
- • Variable cost efficiencies and lower exchange fee rates
- • Total effectuated members grew to approximately 2.04 million from 1.45 million year-over-year
- • Individual and Small Group members grew to 2,021,484 from 1,386,980
OSCR YoY Financials
Q1 2025 vs Q1 2024, source: SEC Filings
“Oscar reported strong financial results in the first quarter. We delivered continued top-line growth and bottom-line performance with significant year-over-year increases in revenue and net income. We continue to expect meaningful margin expansion this year as we deliver superior value to our members and partners.”
— Mark Bertolini, Q1 2025 Earnings Press Release
OSCR Earnings Trends
OSCR vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
OSCR EPS Trend
Earnings per share: estimate vs actual
OSCR Revenue Trend
Quarterly revenue: estimate vs actual
OSCR Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 BEAT | $1.10 | $2.07 | +88.18% | $4.65B | -5.49% |
| Q4 25 MISS FY | $-0.92 | $-1.24 | -34.58% | $2.81B | -10.19% |
| FY Full Year | $-1.29 | $-1.69 | -31.47% | $11.70B | -2.64% |
| Q3 25 BEAT | $-0.58 | $-0.53 | +8.65% | $2.99B | -3.12% |
| Q2 25 MISS | $-0.84 | $-0.89 | -6.46% | $2.86B | -1.87% |
| Q1 25 BEAT | $0.81 | $0.92 | +13.93% | $3.05B | +6.31% |